Senior Director, Pipeline Market Access Strategy - Immunology

AbbVie•Mettawa, IL

8h•$206,500 - $393,000

About The Position

The Senior Director, Pipeline Market Access Strategy (PMAX) leads end-to-end global market access strategy for pipeline assets within an assigned Business Unit. The role integrates pricing and access considerations into drug development from early stages through Phase 3, including clinical trial design, evidence generation, and Target Product Profiles. It defines distinct US and international strategies to support successful global launches and serves as the definitive pipeline market access voice in business and portfolio decisions. The role leads experts in US and international pipeline strategy and partners with inline access teams and functions including R&D, Regulatory, HEOR, Global Commercial Development, Business Development, and Government Affairs. It guides pipeline-to-launch planning, assesses payer and HTA evidence needs, supports asset evaluation and due diligence, and builds a high-performing team. The position requires 25% travel. The stated annual base salary range is USD 206,500 to USD 393,000, depending on factors including geographic location. The role is eligible for long-term incentive programs and offers eligible employees paid time off, medical, dental and vision insurance, and a 401(k).

Requirements

Bachelor's degree in a scientific, business, or public health discipline, at minimum.
Advanced degree (MBA, MPH, PhD, PharmD, or equivalent) in business, health economics, public policy, life sciences, or a related field.
12–15 years of progressive senior-level experience in market access, pricing, reimbursement, HEOR, or a closely related pharmaceutical or biopharmaceutical function, with a substantial portion focused on pipeline and pre-launch strategy.
Deep working knowledge of global market access, HTA processes, payer evidence requirements, pricing and reimbursement frameworks, and access decision-making across the US, EU5, Japan, and other key markets.
Experience shaping clinical development strategy from a market access and outcomes evidence perspective, including contributing to clinical trial design, endpoint selection, and Integrated Evidence Plan development with R&D.
Track record leading and developing high-performing teams in a matrixed, multinational environment, managing direct reports and influencing cross-functional partners without direct authority.
Ability to communicate complex access strategy to executive audiences and influence enterprise-level pipeline investment decisions.
Deep expertise in at least one therapeutic area.
Willingness to travel 25% of the time.

Nice To Haves

Formal training or demonstrated expertise in HTA, health economics, outcomes research, or pharmaceutical development.
Experience supporting Business Development activities, including asset due diligence, licensing evaluations, and access-based valuation assessments.
Experience across multiple therapeutic areas, such as Oncology, Immunology, or Neuroscience.

Responsibilities

Own end-to-end integrated access strategy for pre-launch and development-stage assets in the assigned Business Unit, addressing evidence needs, policy considerations, pricing potential, and commercial considerations through regulatory submission.
Represent pipeline market access strategy at Business Unit governance forums and senior leadership reviews, communicating access risks, opportunities, and strategic direction.
Provide market access input to pipeline Business Development opportunities and lead prioritization of pipeline assets and resources based on access complexity and business impact.
Develop launch strategies that consider IRA, MFN, US channel dynamics, indication sequencing, and geographic sequencing.
Define and deliver a cross-functional Access Roadmap for each pipeline asset, covering development phase, anticipated launch timing, and global evidence deliverables.
Partner with R&D and Regulatory to embed access-relevant endpoints, comparators, and trial design elements into clinical development from Phase I/II onward, including collaboration with affiliates.
Define and champion Target Product Profiles from a market access perspective and translate payer value requirements into clinical and evidence-generation guidance.
Generate and maintain global payer and HTA evidence requirements across the US, EU5, Japan, and emerging markets.
Direct the US Pipeline Strategy Lead and International Pipeline Strategy Lead and integrate domestic and global perspectives into a cohesive Business Unit strategy.
Align US payer strategy, formulary positioning, and value communications with international HTA, pricing, and reimbursement approaches, while adapting to local market requirements.
Anticipate cross-market reference pricing, parallel trade, and HTA precedent risks and incorporate them into pipeline strategies.
Develop and execute pipeline-to-launch transition frameworks with US and international teams, preparing access strategies, payer evidence packages, and reimbursement submissions ahead of approval.
Coordinate knowledge transfer and strategic handoff at regulatory approval, including payer communication plans, launch sequencing, and country-level access readiness assessments.
Lead cross-functional launch readiness reviews to identify and resolve evidence, pricing approval, and formulary positioning gaps before approval.
Ensure affiliate and in-country teams receive aligned value messages, health economic tools, and reimbursement dossiers in advance of launch.
Provide strategic direction and partnership to HEOR, R&D, Regulatory, Global Commercial Development, Global Marketing, Government Affairs, and Business Development.
Lead development of Integrated Evidence Plans with HEOR, aligning real-world evidence, health economic modeling, and outcomes research with anticipated payer and HTA requirements.
Partner with Government Affairs to anticipate and shape policy and reimbursement developments and incorporate policy risks and opportunities into access strategies.
Align pipeline access strategies with brand positioning, indication sequencing, and long-range commercial forecasts in collaboration with Global Commercial Development and Global Marketing.
Support in-licensing, partnership, and acquisition assessments with payer landscape assessments, reimbursement probability analyses, and access risk evaluations.
Establish and communicate access-based licensing priorities that account for payer evidence requirements, competitive access dynamics, and global pricing sustainability.
Serve as the access subject matter expert in due diligence, assessing payer readiness and evidence maturity of external pipeline assets.
Represent pipeline market access priorities at senior governance forums, portfolio review committees, and cross-Business Unit strategy sessions.
Build, develop, and retain a high-performing pipeline access team, providing mentorship, career development, and performance management for direct and indirect reports.
Foster innovation, rigor, and affiliate-centricity, incorporating affiliate launch needs, in-country dynamics, and local payer requirements into global strategy.